| JANX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the JANX shares outstanding history going back to 6/11/2021:
Also see: JANX Market Cap History JANX YTD Return |
JANX Shares Outstanding History — Janux Therapeutics Share Count Over Time
As of 2/24/2026 Janux Therapeutics has 60.83 million JANX shares outstanding. Investors often track the JANX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows JANX share count trends over time, with 20 historical shares outstanding datapoints presented, dating back to 6/11/2021.
| JANX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||
JANX Historical Shares Outstanding: +10.51% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||
| JANX Stock Price Chart |
| About Janux Therapeutics Inc |
| Janux Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. It has developed two bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain. Its clinical candidate includes JANX007 and JANX008. We show 20 historical shares outstanding datapoints in our coverage of JANX's shares outstanding history. Understanding the changing numbers of JANX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like JANX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching JANX by allowing them to research JANX shares outstanding history as well as any other stock in our coverage universe. |
| JANX Current Stock Quote |
Quotes delayed 20 minutes  Free JANX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| JANX Share Performance |
| Shares Outstanding Peers |
| Janux Therapeutics (JANX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
JAZZ Shares Outstanding History JBIO Shares Outstanding History JNCE Shares Outstanding History JNJ Shares Outstanding History JNP Shares Outstanding History JSPR Shares Outstanding History JUNS Shares Outstanding History JUPW Shares Outstanding History KA Shares Outstanding History KA Shares Outstanding History More Healthcare companies » |
JANX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
